Disclosure under regulation 29(2) of SEBI(SAST) Regulations, 2011 received from Ishita Pharmaceuticals, related party of Ishita Drugs and Industries Limited.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ishita Pharmaceuticals, a promoter group / related party of Ishita Drugs & Industries Ltd, bought a total of 1,231 shares of the company (Rs. 10 each) in the open market across two days. On December 2, 2025, it acquired 393 shares (taking holding to 29,152 shares or 0.97%), and on December 3, 2025, it acquired 838 more shares (taking holding to 29,990 shares or 1.00%). Prior to these purchases, the related party held 28,759 shares (0.96%). Total equity share capital of the company remains 29,90,300 shares of Rs. 10 each (Rs. 2.99 crore). The mode of acquisition is open market purchase, and no encumbrance (pledge/lien) is involved.
This is a small promoter-group acquisition of around 0.04% additional stake, showing minor confidence-building buying in the open market. Given the very small size, it is unlikely to meaningfully move the stock price, but signals continued promoter group interest in the company.